Polyglutamine Atrophin provokes neurodegeneration in Drosophila by repressing fat

EMBO J. 2011 Mar 2;30(5):945-58. doi: 10.1038/emboj.2011.1. Epub 2011 Jan 28.

Abstract

Large alterations in transcription accompany neurodegeneration in polyglutamine (polyQ) diseases. These pathologies manifest both general polyQ toxicity and mutant protein-specific effects. In this study, we report that the fat tumour suppressor gene mediates neurodegeneration induced by the polyQ protein Atrophin. We have monitored early transcriptional alterations in a Drosophila model of Dentatorubral-pallidoluysian Atrophy and found that polyQ Atrophins downregulate fat. Fat protects from neurodegeneration and Atrophin toxicity through the Hippo kinase cascade. Fat/Hippo signalling does not provoke neurodegeneration by stimulating overgrowth; rather, it alters the autophagic flux in photoreceptor neurons, thereby affecting cell homeostasis. Our data thus provide a crucial insight into the specific mechanism of a polyQ disease and reveal an unexpected neuroprotective role of the Fat/Hippo pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autophagy
  • Cell Adhesion Molecules / antagonists & inhibitors*
  • Cell Adhesion Molecules / genetics
  • Cell Adhesion Molecules / metabolism*
  • Disease Models, Animal
  • Drosophila / genetics
  • Drosophila / metabolism*
  • Drosophila Proteins / antagonists & inhibitors*
  • Drosophila Proteins / genetics
  • Drosophila Proteins / metabolism*
  • Immunoenzyme Techniques
  • Myoclonic Epilepsies, Progressive / genetics
  • Myoclonic Epilepsies, Progressive / metabolism*
  • Myoclonic Epilepsies, Progressive / pathology*
  • Nerve Degeneration
  • Nerve Tissue Proteins / pharmacology*
  • Neurons / metabolism
  • Neurons / pathology
  • Peptides / genetics*
  • Signal Transduction
  • Transcription, Genetic

Substances

  • Cell Adhesion Molecules
  • Drosophila Proteins
  • Nerve Tissue Proteins
  • Peptides
  • atrophin-1
  • ft protein, Drosophila
  • polyglutamine

Associated data

  • GEO/GSE26246